- Home
- ETD vs OCS Comparison
ETD vs OCS Comparison
Compare ETD & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETD
- OCS
- Stock Information
- Founded
- ETD 1932
- OCS 2003
- Country
- ETD United States
- OCS Switzerland
- Employees
- ETD N/A
- OCS N/A
- Industry
- ETD Home Furnishings
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- ETD Consumer Discretionary
- OCS Health Care
- Exchange
- ETD Nasdaq
- OCS Nasdaq
- Market Cap
- ETD 763.7M
- OCS 869.8M
- IPO Year
- ETD 1993
- OCS N/A
- Fundamental
- Price
- ETD $28.19
- OCS $21.39
- Analyst Decision
- ETD Hold
- OCS Strong Buy
- Analyst Count
- ETD 2
- OCS 4
- Target Price
- ETD $30.00
- OCS $41.00
- AVG Volume (30 Days)
- ETD 207.6K
- OCS 84.0K
- Earning Date
- ETD 10-29-2025
- OCS 11-06-2025
- Dividend Yield
- ETD 6.42%
- OCS N/A
- EPS Growth
- ETD N/A
- OCS N/A
- EPS
- ETD 2.01
- OCS N/A
- Revenue
- ETD $614,649,000.00
- OCS $960,668.00
- Revenue This Year
- ETD $1.12
- OCS $38.85
- Revenue Next Year
- ETD $3.79
- OCS $994.06
- P/E Ratio
- ETD $14.02
- OCS N/A
- Revenue Growth
- ETD N/A
- OCS N/A
- 52 Week Low
- ETD $24.55
- OCS $14.00
- 52 Week High
- ETD $32.61
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- ETD 51.06
- OCS 63.13
- Support Level
- ETD $27.39
- OCS $20.91
- Resistance Level
- ETD $27.85
- OCS $21.84
- Average True Range (ATR)
- ETD 0.56
- OCS 0.64
- MACD
- ETD 0.09
- OCS -0.08
- Stochastic Oscillator
- ETD 86.01
- OCS 56.12
About ETD Ethan Allen Interiors Inc.
Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.